Fundz

Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer

PRIVATEFeb 17, 2026

Position

Chief Regulatory Officer

Company

Ray Therapeutics

Michael Murtagh
San DiegoBiotechnologyHealth CareScience And Engineering

Description

Ray Therapeutics announced the appointment of Michael Murtagh as Chief Regulatory Officer. He brings over 20 years of experience in regulatory affairs to help develop innovative optogenetic gene therapies.

Quick answer

Ray Therapeutics Appoints Michael Murtagh as Chief Regulatory Officer (February 17, 2026). Ray Therapeutics is based in San Diego, California, United States.

Who is the new Chief Regulatory Officer at Ray Therapeutics?
Ray Therapeutics named Michael Murtagh Chief Regulatory Officer, announced February 17, 2026.
What did Ray Therapeutics announce on February 17, 2026?
Ray Therapeutics announced the appointment of Michael Murtagh as Chief Regulatory Officer. He brings over 20 years of experience in regulatory affairs to help develop innovative optogenetic gene therapies.
What does Ray Therapeutics do?
Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases.
Where is Ray Therapeutics based?
Ray Therapeutics is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Nomad Power Solutions, Inc. (February 18, 2026), Bio-Techne Corporation (February 11, 2026), AN2 Therapeutics (January 29, 2026) and Cardiff Oncology (January 27, 2026) also announced leadership changes within 45 days of Ray Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Ray Therapeutics, and when

A new leader at Ray Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Ray Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ray Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ray Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ray Therapeutics

Location

San Diego, California, United States

About

Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate Ray-001 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need. The company’s mission is to use optogenetics to restore vision, independent of genetic mutation for patients with inherited retinal diseases. Ray Therapeutics is based in San Diego, CA. For additional information, please visit www.raytherapeutics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ray Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ray Therapeutics's next move

Learn about Strategic plan

Ray Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.